Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors.
Yang D, Duan MH, Yuan QE, Li ZL, Luo CH, Cui LY, Li LC, Xiao Y, Zhu XY, Zhang HL, Feng GK, Liu GC, Deng R, Li JD, Zhu XF.
Yang D, et al. Among authors: zhu xy, zhu xf.
J Transl Med. 2023 Sep 1;21(1):586. doi: 10.1186/s12967-023-04422-x.
J Transl Med. 2023.
PMID: 37658364
Free PMC article.